Impact BioMedical, Inc. (IBO)

Impact BioMedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021
Cash & Equivalents	0	0.05
Short-Term Investments	0.02	0.2
Cash & Cash Equivalents	0.02	0.24
Cash Growth	-92.59%	-
Other Current Assets	0.1	0.04
Total Current Assets	0.12	0.29
Property, Plant & Equipment	0.28	-
Long-Term Investments	0.97	9.9
Goodwill and Intangibles	45.13	46.24
Total Long-Term Assets	46.38	56.14
Total Assets	46.5	56.43
Accounts Payable	0.54	0.12
Current Debt	9.99	12.52
Other Current Liabilities	0.06	0.01
Total Current Liabilities	10.59	12.65
Other Long-Term Liabilities	3.24	3.86
Total Long-Term Liabilities	3.24	3.86
Total Liabilities	13.83	16.5
Total Debt	9.99	12.52
Debt Growth	-20.23%	-
Retained Earnings	-8.63	-1.57
Shareholders' Equity	32.67	39.92
Net Cash / Debt	-9.97	-12.28
Working Capital	-10.47	-12.36

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).